Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Takeda Pharmaceutical Ord Shs
(OP:
TKPHF
)
30.83
UNCHANGED
Streaming Delayed Price
Updated: 10:17 AM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
30.83
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
30.83
Today's Range
30.83 - 30.83
52wk Range
24.25 - 32.13
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Current Analysis: Takeda Pharmaceutical
↗
April 09, 2024
Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. Over the past year, Takeda’s share price fell 20.5% from $34.04 to $27.05 as of...
Via
Talk Markets
Current Analysis: Takeda Pharmaceuticals (TKPHF)
↗
November 12, 2023
TKPHF is the largest Japanese drug company. Furthermore the estimated $45.50 dividend income from $1k invested is about 1.64 times greater than Friday’s price of a single share
Via
Talk Markets
Performance
YTD
N/A
N/A
1 Month
+6.8%
+6.8%
3 Month
+13.5%
+13.5%
6 Month
+5.2%
+5.2%
1 Year
+8.9%
+8.9%
More News
Read More
Takeda Moves Out From Licensing Agreement With Theravance Biopharma
↗
May 11, 2023
Via
Benzinga
Takeda's FY22 Net Profit Jumps 38%, But Expects Lower FY23 Revenues
↗
May 11, 2023
Via
Benzinga
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
↗
April 21, 2023
Via
Benzinga
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
↗
December 13, 2022
Via
Benzinga
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
↗
November 23, 2022
Via
Benzinga
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
↗
October 27, 2022
Via
Benzinga
Takeda Seeks FDA Approval For Hereditary Angioedema Treatment For Younger Kids
↗
October 05, 2022
Via
Benzinga
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says
↗
March 20, 2023
Via
Benzinga
Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients
↗
February 21, 2023
Via
Benzinga
Takeda Reports 13% Fall In Nine Month Operating Profit, Keeps Annual Guidance Unchanged
↗
February 02, 2023
Via
Benzinga
Why Shares of Phathom Pharmaceutical Jumped This Week
↗
January 28, 2023
Via
The Motley Fool
Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study
↗
January 09, 2023
Via
Benzinga
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
December 06, 2022
From
Singapore Economic Development Board (EDB)A*STAR
Via
ACN Newswire
Takeda Touts Encouraging Data For Hyqvia In Rare Nerve Inflammation Disorder
↗
July 21, 2022
Via
Benzinga
Takeda Pharma Clocks 1% Increase In FY21 Core Profit, Expects Growth Momentum In FY22
↗
May 11, 2022
Via
Benzinga
Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings
↗
November 17, 2022
Via
Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
↗
August 30, 2022
Via
Benzinga
After Six Years Of Collaboration, Takeda Walks Away From Microbiome Drug Pact
↗
August 26, 2022
Via
Benzinga
EXCLUSIVE: Takeda's Cancer Partner BridGene Raises $38.5M To Accelerate Work On Undruggable Targets
↗
July 27, 2022
Via
Benzinga
Takeda's Hereditary Angioedema Treatment Prevents Attacks In Kids Below 12 Years
↗
July 01, 2022
Via
Benzinga
Takeda's Maribavir Reduces Hospitalization Rates, Hospital Stay In Post-Transplant Infection Patients
↗
April 22, 2022
Via
Benzinga
Takeda's Angioedema Drug Shows Promising Action Against COVID-19 Infection
↗
March 08, 2022
Via
Benzinga
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
↗
February 22, 2022
Via
Benzinga
Frequently Asked Questions
Is Takeda Pharmaceutical Ord Shs publicly traded?
Yes, Takeda Pharmaceutical Ord Shs is publicly traded.
What exchange does Takeda Pharmaceutical Ord Shs trade on?
Takeda Pharmaceutical Ord Shs trades on the OTC Traded
What is the ticker symbol for Takeda Pharmaceutical Ord Shs?
The ticker symbol for Takeda Pharmaceutical Ord Shs is TKPHF on the OTC Traded
What is the current price of Takeda Pharmaceutical Ord Shs?
The current price of Takeda Pharmaceutical Ord Shs is 30.83
When was Takeda Pharmaceutical Ord Shs last traded?
The last trade of Takeda Pharmaceutical Ord Shs was at 12/31/25 10:17 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.